//

 Y Combinator is pulling the curtains off of a new experiment, YC Bio. The idea is to fund early-stage life-sciences companies that are still in the lab phase, YC President Sam Altman wrote on the YC blog today. YC Bio’s first area of focus will be on healthspan and age-related disease. “We think there’s an enormous opportunity to help people live healthier for longer, and that… Read More

from Startups – TechCrunch http://ift.tt/2mtKYEL